South East Asia New-born screening market is growing at a CAGR of 10.17% in the forecast period of 2022-2029.New-born screening means a group of special tests, together with blood, hearing, and heart screening, done to one- to two-day-old infants, commonly before they leave the hospital. This can be to envision for any serious health disorders that don't show signs at birth.The "immunoassays and enzymatic assays" accounts for the largest technology segment in the newborn screening market within the forecasted period owing to wide usage of these assays to screen for disorders in newborns. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.


Get the sample copy of Report here@-

Test Type

  • Dried Blood Spot Test
  • Hearing Screen Test
  • Critical Congenital Heart Diseases (CCHD) Test

On the basis of test type, the newborn screening market is segmented into dried blood spot test, hearing screen test and critical congenital heart diseases (CCHD) test.

Product Type

  • Instruments
  • Reagents
  • Assay Kits

On the basis of product type, the newborn screening market is segmented into instruments, reagents and assay kits.


  • Tandem Mass Spectrometry
  • Hearing Screen Technology
  • Pulse Oximetry Screening Technology
  • Immunoassays and Enzymatic Assays
  • Electrophoresis
  • DNA-Based Assays

 Disease Type

  • Critical Congenital Heart Diseases
  • Newborn Hearing Loss
  • Sickle Cell Disease
  • Phenylketonuria (PKU)
  • Cystic Fibrosis (CF)
  • Maple Syrup Urine Disease
  • Others

End User

  • Hospital
  • Paediatric Clinics
  • Clinics

On the basis of end user, the newborn screening market is bifurcated into hospital, paediatric clinics and clinics.

  • Based on test type, the South East Asia New-born screening market is segmented into dried blood spot test, hearing screen test, critical congenital heart diseases. 
  • Based on product type, the South East Asia New-born screening market is segmented into instrument, consumables, hearing screening instruments, and pulse oximeters. Consumables is further segmented into assay kits & reagents, other consumables. Other consumables is further sub-segmented into columns and screening cards. Instruments is further segmented into disorder screening instruments, fully-automated instruments, other instruments. Other instruments is further sub-segmented into semi-automated instruments, shakers, incubatorea and etc. Hearing screening instruments is further segmented into accessories, devices.
  • Based on technology, the South East Asia New-born screening market is segmented into tandem mass spectrometry, hearing screen technology, pulse oximetry screening technology, immunoassays and enzymatic assays, electrophoresis, DNA-based assays.
  • Based on disease type, the south East Asia New-born screening market is segmented into critical congenital heart diseases, New-born hearing loss, sickle cell disease, phenylketonuria (PKU), cystic fibrosis (CF), and maple.
  • Based on end user, the South East Asia New-born screening market is segmented into hospital, paediatric clinics.



Get Full Access of Report@-

Highlight of Table of Content:

§  Chapter 1: Market overview

§  Chapter 2: Global Newborn Screening Market Analysis

§  Chapter 3: Regional analysis of the Global Newborn Screening Market

§  Chapter 4: Market segmentation based on types and applications

§  Chapter 5: Revenue analysis based on types and applications

§  Chapter 6: Market share

§  Chapter 7: Competitive Landscape

§  Chapter 8: Drivers, Restraints, Challenges, and Opportunities

§  Chapter 9: Gross Margin and Price Analysis

Get Details free TOC of this report@

Some of the major players operating in the newborn screening market are PerkinElmer Inc., (U.S), Demant A/S (Denmark), Natus Medical Incorporated (U.S), Bio-Rad Laboratories (U.S), Luminex Corporation (US),  F. Hoffmann-La Roche Ltd., (Switzerland), Thermo Fisher Scientific Inc., (U.S), Bruker (US),  Danaher (US), Medtronic (Ireland), Chromsystems Instruments & Chemicals GmbH (Germany), Trivitron Healthcare (India), Baebies Inc., (U.S), and RECIPE Chemicals + Instruments GmbH (Germany) among others.

Profound Questions Answered in this Report:

·       What is the growth rate of various stages in the value chain of the industry?

·       Which region has the highest growth rate and size of the emerging market by value in 2021?

·       Who are the competitive players in Global Newborn Screening Market?

·       Which region has the largest share and degree of competition in the industry?

·       What is the CAGR of the market during the forecast period till 2029?

·       Which region is expected to hold the highest market share for the market?

·       What is the main driver of the Global Newborn Screening Market?

·       What is sales volume, revenue, and price analysis of top players of the market?

·       What are the market opportunities and threats faced by the vendors in the industry?

·       What has been the impact of COVID-19 on Global Newborn Screening Market?


Browse Related Blogs@-

Microarray Instruments and Reagents Market

Clinical Trial Consumables Market

Hereditary Angioedema Therapeutic Market


About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market



Data Bridge Market Research

Tel: +1-888-387-2818